Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.

27.38 0.38 −1.37%
Market cap
$2.3B
P/E
13.1×
Fwd P/E
11.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

8.82 11.03 10.38 12.12
P/S ratio
0.74 0.94 0.90 1.03
P/FCF ratio
5.18 7.12 7.29 8.80
P/Operating CF
10.32 15.76 (13.32) 16.06
P/B ratio
1.59 2.08 1.97 2.28
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.81 0.99 1.03 1.12
EV/EBITDA
6.97 8.19 8.24 9.17
EV/Operating CF
5.37 6.99 7.70 8.88
EV/FCF
5.69 7.51 8.39 9.59
Quick Ratio
1.78 1.62 1.28 1.28
Current Ratio
1.83 1.66 1.33 1.32
Net Debt/EBITDA
1.89 1.79 5.47 2.87
Debt/Assets
27.39% 26.59% 28.54% 27.42%
Debt/Equity
0.68 0.69 0.67 0.66
Asset Turnover
0.90 0.87 0.95 0.92
Operating CF/Net income
1.91 3.39 (4.39) 3.15
Capex/Depreciation
(0.92) (0.90) (1.00) (0.24)
Interest Coverage
7.61 5.58 5.04 6.97
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.33% 13.30% 12.66% 12.57%
Intangible Assets out of Total Assets
0.58 0.57 0.62 0.60
Share Based Compensation of Revenue
1.04% 1.08% 0.98% 1.04%
Graham Net Nets
(0.42) (0.34) (0.35) (0.29)
Graham Number
21.21 21.20 22.44 22.84
Earnings Yield
11.34% 9.07% 9.63% 8.25%
Free Cash Flow Yield
19.29% 14.05% 13.72% 11.36%
Revenue per Share
5.83 5.87 5.89 6.14
Operating CF per Share
1.62 1.36 (1.61) 1.58
Capex per Share
(0.06) (0.06) (0.08) (0.02)
Free Cash Flow per Share
1.56 1.29 (1.68) 1.56
Cash per Share
5.47 5.94 4.07 5.09
Shareholders Equity per Share
10.53 10.30 10.86 11.09
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
10.53 10.30 10.86 11.09
Free Cash Flow
131.95 108.82 (136.09) 123.94
Working Capital
324.65 304.60 144.40 158.56
Capital Expenditures
(5.34) (5.29) (6.25) (1.38)
Net Current Asset Value
(591.54) (617.33) (604.68) (589.22)
EV/EBIT
7.81 9.08 9.12 10.18
Capex to Sales
0.01 0.01 0.01 0.00
Price to Operating Income
7.11 8.61 7.92 9.34
Other line items
Average Receivables
261.52 257.46 244.90 242.81
Average Payables
342.86 409.11 235.55 302.60
Average Assets
2,138.14 2,199.70 2,031.89 2,116.22
Average Common Equity
811.58 815.40 833.88 857.37

Fold the line items

Columns are period end dates